Overview
Highly purified sheep hyaluronidase for administration by injection into the vitreous of the eye.
Indication
For increase of absorption and distribution of other injected drugs and for rehydration.
Associated Conditions
- Chronic Lymphocytic Leukemia
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Follicular Lymphoma ( FL)
- Refractory Follicular Lymphoma
- Relapsed Follicular Lymphoma
- Non-progressive Follicular Lymphoma
- Stable Follicular Lymphoma
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2005/09/20 | Phase 4 | Completed | |||
2005/09/20 | Phase 1 | Completed | |||
2005/09/20 | Phase 3 | Completed | |||
2005/09/20 | Phase 2 | Completed | |||
2005/09/20 | Phase 3 | Completed | |||
2005/09/20 | Phase 1 | Completed | |||
2005/09/20 | Phase 3 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| HYALASE POWDER FOR INJECTION 1500 iu/ampoule | SIN10302P | INJECTION, POWDER, FOR SOLUTION | 1500 iu/ampoule | 10/23/1998 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.